Propanc Biopharma, Inc. (PPCB) income statement
PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30
$1.76−0.12 (-6.38%)
Close on Nov 18, 2026Market cap $1.73MP/E –Yield –
Propanc Biopharma, Inc. financial ratios
See a number that looks wrong?